Results 201 to 210 of about 236,558 (261)

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea, Dario Colacurci, Giorgia D'Apice, Laura Letizia Mazzarelli, Massimiliano Pellicano, Luigi Falco, Ginevra Sepe, Oriana Imperatore, Giuseppe Maria Maruotti, Maurizio Guida, Laura Sarno   +10 more
wiley   +1 more source

Factors Associated with Viral Load Suppression Among People Living with HIV on Antiretroviral Therapy in Bunia, Northeastern Democratic Republic of Congo. [PDF]

Diseases
Kwendra AL, Mouinga-Ondeme A, Engone-Ondo JD, Tsedha RB, Ngona JB, Agasa SB, Ngadjole HC, Mfouo-Tynga IS, Kibendelwa ZT.   +8 more
europepmc   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page 1412-1416, October 2026.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

HIV-1 Drug Resistance Mutations in Children: A Systematic Review of Global Genotypic Evidence (2014-2026). [PDF]

Pathogens
Jouf G, Alami AB, Maazaz N, Benchekroun S, Elharti E, Belbacha I, Ihazmad H, Jaoudi RE, Benhida R, Rchiad Z, Oumzil H.   +10 more
europepmc   +1 more source

HPV42 – ein als Niedrigrisiko‐Typ klassifiziertes humanes Papillomvirus mit onkogenem Potenzial

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page 1412-1417, October 2026.
Zusammenfassung Das humane Papillomvirus (HPV) Typ 42 ist ein seltener, derzeit als low‐risk klassifizierter HPV‐Typ, der zum Papillomvirus‐Genus alpha gehört. In benignen vulvären Papillomen nachgewiesen, verursacht HPV42 überwiegend benigne Läsionen wie anogenitale Warzen.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

Health interventions do not cause Malthusian conflict dynamics: Evidence from the expansion of HIV treatment in Africa. [PDF]

PLOS Glob Public Health
Berlanda A, Cervellati M, Esposito E, Rohner D, Sunde U.   +4 more
europepmc   +1 more source

Retention in care among women with HIV: A systematic review of treatment continuity during pregnancy and postpartum

HIV Medicine, Volume 27, Issue 10, Page 1584-1596, October 2026.
Abstract Introduction Pregnant women with HIV are at risk of reduced engagement in HIV care during pregnancy and postpartum. Retention in care, defined as continuous engagement in HIV‐related treatment and follow‐up, is essential to achieve virological suppression and prevent vertical transmission.
Stine Hansen, Klara Tetzschner Madsen, Nina Weis, Ellen Moseholm   +3 more
wiley   +1 more source

The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV. [PDF]

Front Cardiovasc Med
Ramos Alejos-Pita C, Rodríguez Torres DJ, Mata Forte T, Tendero de la Asunción B, Gómez Sanz JE, Reyes Luján JJ, Romano M, López Soberón E, Membrillo de Novales FJ, Estébanez Muñoz M.   +9 more
europepmc   +1 more source

Death after discharge among children living with HIV admitted with suspected sepsis in Uganda: A secondary analysis of two prospective observational studies

HIV Medicine, Volume 27, Issue 10, Page 1597-1608, October 2026.
Abstract Background Children living with HIV in low‐income countries contribute disproportionately to death after hospital discharge. This study investigates the effect of HIV on post‐discharge mortality and readmission by exploring a wide range of clinical, maternal and socioeconomic variables.
O. Mackenzie, C. Zhang, N. Kissoon, N. Ford, N. Sugandhi, E. Kumbakumba, J. Kabakyenga, C. Komugisha, N. K. Mugisha, M. O. Wiens   +9 more
wiley   +1 more source